Sanjeev Pathak

Summary

Affiliation: AstraZeneca R and D

Publications

  1. ncbi Efficacy and safety of quetiapine in children and adolescents with mania associated with bipolar I disorder: a 3-week, double-blind, placebo-controlled trial
    Sanjeev Pathak
    AstraZeneca Pharmaceuticals LP, Wilmington, DE, USA
    J Clin Psychiatry 74:e100-9. 2013
  2. pmc Development and content validity of a patient reported outcomes measure to assess symptoms of major depressive disorder
    Kathryn Eilene Lasch
    Adelphi Values, Boston, MA, USA
    BMC Psychiatry 12:34. 2012

Collaborators

Detail Information

Publications2

  1. ncbi Efficacy and safety of quetiapine in children and adolescents with mania associated with bipolar I disorder: a 3-week, double-blind, placebo-controlled trial
    Sanjeev Pathak
    AstraZeneca Pharmaceuticals LP, Wilmington, DE, USA
    J Clin Psychiatry 74:e100-9. 2013
    ..To evaluate the efficacy and safety of quetiapine monotherapy in children and adolescents with mania associated with bipolar I disorder...
  2. pmc Development and content validity of a patient reported outcomes measure to assess symptoms of major depressive disorder
    Kathryn Eilene Lasch
    Adelphi Values, Boston, MA, USA
    BMC Psychiatry 12:34. 2012
    ..The aim of this study was to develop a disease-specific questionnaire to assess symptoms important and relevant to adult MDD patients...